ticker

American Airlines: Flying on Faith

alex
25 Jun, 2003
New York City

As long as only the capital structure is changing, but not the management handling of the business and the relationship with the unions, all the new cash obtained, earned in good times, or secured through guarantees will be still burned out, eventual

Amgen - Top Investment Choice

kalina
30 Apr, 2003
New York City

Biotechnology giant Amgen has successfully managed to not only grow stronger during an economic recession but also emerge as a compelling long-term investment choice.

Eli Lilly Leads Pack of Pharma Players

kalina
16 Apr, 2003
New York City

Pharmaceutical bellwether Eli Lilly faced a considerable drop in revenue after the patent expiry of Prozac, but its healthy pipeline could more than offset this loss.

Investors Go Back to School

vanya
07 Apr, 2003
New York City

Smart investors have realised that even in times of economic and geopolitical uncertainty, some education industry players offer profits and growth that are hard to find elsewhere.

Celgene: Cruising Towards Profitability

kalina
02 Apr, 2003
New York City

Even as research efforts of most biotechs are stumbling along without success, Celgene has actually widened its cancer-research program and is fast cruising towards profitability.

Weight Watchers Gains from War on Fat

vanya
25 Mar, 2003
New York City

At a time when the war on Iraq is driving stock markets, Weight Watchers is gaining on another one - the war on fat - as Americans spend billions on weight-loss programs & products.

Biotech M&A Activity Rises, FDA Acts Catalyst

kalina
17 Mar, 2003
New York City

The growing number of deals in the biotech arena suggests sector consolidation is finally under way. The FDA's recent publication of a key report is also becoming a major catalyst.

Growth Opportunities in Network Security

vanya
09 Mar, 2003
New York City

Even though several IT markets are declining, investors can still find growth opportunities in the security sector - particularly, in the firewall/VPN segment.

Blood Cancer Drugs Drive IDEC

kalina
03 Mar, 2003
New York City

The shaky economy has pushed all stocks, including biotechs, to face tough times. Yet, IDEC Pharmaceuticals is one company worth betting on in this highly volatile sector.

Fighting Spam

vanya
24 Feb, 2003
New York City

As spam - or unsolicited e-mail - continues to plague corporate networks, the army of vendors offering defences is growing as well. Will fighting spam become big business?

Biotechs on the Mend; Biogen Triumphs

kalina
16 Feb, 2003
New York City

Despite the many uncertainties associated with the biotech sector, there are several worthy investment choices. Biogen, which got two regulatory approvals lately, is one of them.

Will 2003 Bring an Uptick in the VC Business?

vanya
10 Feb, 2003
New York City

Last year was a sobering one for venture capitalists as investment activity finished at a pace that was the slowest in nearly five years. Will 2003 be better for the VC business?

Johnson & Johnson: Quality at Good Price

kalina
03 Feb, 2003
New York City

Having managed to grow even during an economic slowdown, healthcare and pharma industry top dog Johnson & Johnson, is poised to attain greater heights in the long run.

Business Intelligence Gathers Momentum

vanya
27 Jan, 2003
New York City

Investors have become skittish about software makers, but it might be smart to keep an eye on business intelligence

JP Morgan Meet Puts Biotechs in the Spotlight

kalina
20 Jan, 2003
New York City

The JP Morgan Healthcare meet did little to boost sector stocks, which were already negatively impacted by a slew of bad news. But the market climate is likely to get better soon.

Market Update